Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response
| Autor: | Yhim, Ho-Young, Lee, Na-Ri, Song, Eun-Kee, Yim, Chang-Yeol, Jeon, So Yeon, Shin, Seunghwan, Kim, Jeong-A, Kim, Hee Sun, Cho, Eun Hae, Kwak, Jae-Yong |
|---|---|
| Zdroj: | In Leukemia Research June 2012 36(6):689-693 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect